The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update – Notification of Change of Venue

19 Mar 2020 16:30

RNS Number : 8600G
Maven Income and Growth VCT 5 PLC
19 March 2020
 

MAVEN INCOME AND GROWTH VCT 5 PLC

2020 AGM UPDATE - NOTIFICATION OF CHANGE OF VENUE

Maven Income and Growth VCT 5 PLC (the Company) announced its Annual Financial Results for the year to 30 November 2019 on 11 March 2020, including notice that the Annual General Meeting (AGM) would be held in London on Tuesday, 28 April 2020 at 11.30 am.

In respect of the evolving Coronavirus (COVID-19) situation, which the Board is monitoring closely, the Directors of the Company consider the well-being of its Shareholders and other AGM attendees as a high priority. Based on the latest available advice, the AGM is expected to proceed on 28 April 2020 as planned, however, the Board has resolved that the venue of the AGM should be moved from London to Glasgow.

Accordingly, the Company's 2020 AGM will be held on Tuesday, 28 April 2020 at 11.30 am at the offices of Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW.

In further consideration of the current situation, Shareholders should also note that only the formal business set out in the Notice of Annual General Meeting, as included in the Annual Report for the year ended 30 November 2019 published on 11 March 2020, will be considered at the AGM and that there will be no presentation by the Manager. The meeting will be conducted swiftly and the room will be vacated promptly following the close of the meeting. No refreshments will be served.

The Directors are aware that the AGM is a good opportunity for Shareholders to meet the Board and the Manager. However, given the possible health risks arising from travel to, and interaction at, the AGM, Shareholders are actively encouraged to consider whether their attendance at the AGM is necessary. Shareholders wishing to vote on any of the matters of business are urged to do so through completion of a Proxy Form, which can be submitted to the Company. Proxy Forms should be completed and returned in accordance with the instructions thereon and the latest time for the receipt of Proxy Forms is 11.30 am on Friday, 24 April 2020. Proxy votes can be also be submitted by CREST or on-line using the Registrar's Share Portal Service at www.signalshares.com.

The Board would, therefore, encourage Shareholders not to attend in person and instead submit any questions by e-mail or by letter in advance of the AGM. A summary of responses will be published after the AGM on the Company's website at: www.mavencp.com/migvct5.

Shareholders wishing to submit a question should write to:

The Company Secretary, Maven Income and Growth VCT 5 PLC, c/o Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW or email

CoSec@mavencp.com

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

19 March 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUKRNRRNUOAAR
Date   Source Headline
5th Nov 20144:20 pmRNSTransaction in Own Shares
4th Nov 201411:46 amRNSTransaction in Own Shares
3rd Nov 20143:59 pmRNSTransaction in Own Shares
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
9th Oct 201412:30 pmRNSInterim Management Statement
3rd Oct 20144:27 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
21st Aug 20141:09 pmRNSTransaction in Own Shares
14th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 201412:27 pmRNSTransaction in Own Shares
12th Aug 20142:38 pmRNSTransaction in Own Shares
11th Aug 20144:08 pmRNSTransaction in Own Shares
5th Aug 201411:36 amRNSReplacement Director/PDMR Shareholding
1st Aug 20143:23 pmRNSDirector/PDMR Shareholding
1st Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20143:19 pmRNSDirector/PDMR Shareholding
30th Jul 201411:12 amRNSHalf Yearly Report
4th Jul 20144:34 pmRNSReplacement re Issue of Equity
3rd Jul 20144:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20149:51 amRNSIssue of Equity
28th May 20145:13 pmRNSOffer for Subscription Update
27th May 201410:35 amRNSDirector Declaration
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:52 pmRNSOffer for Subscription - Supplementary Prospectus
22nd Apr 20143:00 pmRNSResult of AGM
22nd Apr 20142:58 pmRNSDirectorate Change
17th Apr 20143:57 pmRNSInterim Management Statement
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.